Assistant Manager (Research Pathologist)

Overview The Consortium for Clinical Research and Innovation, Singapore (CRIS) brings together seven national R&D, clinical translation, and service programmes to advance clinical research and innovation for Singapore and establish important capabilities for a future-ready healthcare system. The Business Entities under CRIS include: • Singapore Clinical Research Institute (SCRI) • National Health Innovation Centre (NHIC) • Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) • Precision Health Research, Singapore (PRECISE) • Singapore Translational Cancer Consortium (STCC) • Cardiovascular Disease National Collaborative Enterprise (CADENCE) • Singapore Medical Foundation AI Model (SIMFONI) Together, CRIS makes a positive difference to Singapore patients and researchers by ensuring that these clinical research platforms and programmes are at the cutting edge of capability development and innovation. If you are as passionate as we are in advancing clinically relevant cancer research, we invite you to join us. The Singapore Translational Cancer Consortium (STCC) aims to strengthen the overall impact of cancer research and translation in Singapore by bringing together key basic, clinical and translational teams on joint platforms to actively establish and implement collaborative cancer programmes. STCC is part of the Consortium for Clinical Research and Innovation Singapore (CRIS) umbrella of research-related business entities and is supported by the National Research Foundation, Singapore (NRF) and the Singapore Ministry of Health through the National Medical Research Council (NMRC) Office, MOH Holdings Pte Ltd. STCC; a nationally coordinated consortium to synergise cancer research capabilities in Singapore, brings together unmatched basic, clinical, and translational talent in Singapore to create globally significant peaks of excellence in selected Asian cancers. STCC's five joint platforms – Cancer Clinical Trials and Investigational Medicine Units, Cancer Databases and Tissue Banks, Translational Research Integration and Support, Business Intelligence and Development, and Impact and Population Health – provide an enabling research and innovation environment driven to foster translational research and meaningful outcomes for society. Through collaborative relationships with our partner institutions [comprising of National Cancer Centre Singapore (NCCS), National University Cancer Institute, Singapore (NCIS), National University Hospital (NUH), National University of Singapore (NUS) and Tan Tock Seng Hospital (TTSH)], and by capitalizing on the strengths of industry and academia, STCC is uniquely poised to develop initiatives that are aligned with Singapore's goals in value-based healthcare innovation and economic value creation. About the Role The Research Pathologist (Senior Executive / Assistant Manager) will provide dedicated pathology expertise within STCC’s Translational Research Integration & Support platform, strengthening pathology support within the translational research pipeline. This role supports pathology-dependent activities including case review, tissue annotation, biomarker assessment, and validation of spatial and AI-derived outputs, enabling high-quality, standardised datasets for multi-institutional studies. This position is integral to advancing STCC’s mission of facilitating impactful translational clinical research through strong data stewardship, cross‑institutional coordination, and responsive operational support. Key Responsibilities Pathology review and case selection Provide input on study design, sample suitability, and feasibility considerations Perform pathology review for research cases, including diagnosis confirmation and histological classification Liaise with investigators to align on case selection requirements Support cohort selection based on study-specific eligibility criteria Tissue annotation and data generation Provide detailed annotation of tissue samples (e.g. tumour regions, microenvironment features) Guide selection of regions of interest for downstream assays (e.g. spatial profiling) Review and validate outputs from spatial omics, digital pathology, and AI-based analyses Biomarker assessment and IHC scoring Perform and/or review immunohistochemistry (IHC) scoring Establish or harmonise IHC scoring criteria and interpretation frameworks across studies Support cross-institutional consistency in biomarker assessment Clinical data curation support Support clin…